BioPharm International, December 2010 Issue (PDF)
A Single-Use System for Safe Freeze–Thaw
Getting Better at Making Stuff
To achieve manufacturing excellence, biopharma companies must adopt four key operating principles.
Safe Freeze–Thaw of Protein Drug Products: A QbD Approach
Apply a DoE strategy to test several formulations in parallel.
Winning Big
Covance's deal with Sanofi-Aventis demonstrates the power of scale and scope.
New Adventures
Biotech, and bioprocessing more specifically, is a great place to be. But it's time for a new adventure.
Public–Private Partnerships: Life-Saving Mechanisms of Action
Managing partnerships for the greater good.
Biotech Manufacturers Face New Political Landscape
Changes on Capital Hill create uncertainty for healthcare reform, drug regulation, and biomedical research.
Managing Raw Materials in the QbD Paradigm, Part 2: Risk Assessment and Communication
Evaluate and communicate risk to stakeholders.
Implementing Disposables Technology, Delivering Innovation, and Transforming an Organization
Sanofi Pasteur's disposables implementation plan is part of a larger evaluation of technology innovation. Here's how they approach it.
